Wall Street giant Morgan Stanley promoted 173 of its employees to managing director roles this year, marking a 12% increase ...

Among 26 home price forecast models tracked by ResiClub, Morgan Stanley is the most bearish on the 2025 housing market.

Morgan Stanley is a buy on weakness with strong dividend growth and projected revenue growth in Q4 2024 and early 2025. Click for our MS earnings preview.

Morgan Stanley Mortgage Capital Holdings has scheduled a foreclosure auction for the 2.2M SF office park near the ...

Morgan Stanley’s Asia wealth chief is looking to boost the number of staff dealing with its richest customers as the US ...

Morgan Stanley analysts have outlined a bearish outlook on the Australian banking sector due to record price-to-earnings ...

At Morgan Stanley, the new class is the first set of MD promotions under chief executive Ted Pick, who took the helm of the ...

Investing.com -- Hermes shares are edging up, rebounding from intraday lows after Morgan Stanley (NYSE: MS) highlighted the ...

Morgan Stanley (NYSE:MS) analysts have upgraded Vir Biotechnology (NASDAQ:VIR) to an "overweight" rating, shifting from "equal-weight," and have also increased their price target to $20 from $10. The ...

Jim Caron of Morgan Stanley Investment Management explains what's behind the steepening yield curve and what it's telling us ...

We recently published a list of Top 10 AI Stocks on Wall Street’s Radar. In this article, we are going to take a look at ...

Morgan Stanley upgraded Vir Biotechnology (NASDAQ:VIR) to Overweight from Equal Weight on Thursday after the cancer drug ...